| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |